Free Trial
NYSEARCA:KURE

KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News

$16.02 +0.10 (+0.60%)
As of 10:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE)

Key Stats

Today's Range
$16.00
$16.15
50-Day Range
$13.39
$16.00
52-Week Range
$12.91
$20.51
Volume
11,069 shs
Average Volume
42,718 shs
Market Capitalization
$85.68 million
Assets Under Management
$83.84 million
Dividend Yield
1.12%
Net Expense Ratio
0.65%
Aggregate Rating
Moderate Buy

ETF Overview

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.

KraneShares MSCI All China Health Care Index ETF Expenses

TypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.78%0.57%0.57%0.52%0.53%
Other Expenses0.01%0.30%0.48%0.56%0.51%
Total Expense0.79%0.70%0.72%0.73%0.71%
Fee Waiver-0.14%-0.45%-0.49%-0.65%-0.54%
Net Expense0.65%0.61%0.63%0.58%0.60%
Receive KURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter.

KURE ETF News Headlines

URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
KURE KraneShares MSCI All China Health Care Index ETF
See More Headlines

KURE ETF - Frequently Asked Questions

KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 at the start of the year. Since then, KURE stock has increased by 12.9% and is now trading at $16.0150.
View the best growth stocks for 2025 here
.

KraneShares MSCI All China Health Care Index ETF's top institutional investors include OLD Mission Capital LLC (3.65%) and Jane Street Group LLC (1.27%).

Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA).

Fund Details

Issuer
KraneShares
Fund Name
KraneShares MSCI All China Health Care Index ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:KURE
Inception Date
1/31/2018
Fund Manager
Mark Schlarbaum
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
MSCI China All Shares Health Care 10/40 Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
54

Fund Statistics

Assets Under Management
$83.84 million
Average Daily Volume
$18,668.70
Discount/Premium
0.10%

Administrator, Advisor and Custodian

Administrator
SEI Investments Global Funds Services
Advisor
Krane Funds Advisors, LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
N/A
Short Interest
7,100 shs

Miscellaneous

Beta
0.20
Creation Unit
50,000
Creation Fee
$1,320.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 KURE Holdings

  • Jiangsu Hengrui Medicine Co., Ltd.
    Holding Weight: 8.34%
  • BeiGene, Ltd.
    Holding Weight: 8.22%
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Holding Weight: 6.80%
  • WuXi Biologics (Cayman) Inc.
    Holding Weight: 6.37%
  • Innovent Biologics, Inc.
    Holding Weight: 5.45%
  • Akeso, Inc.
    Holding Weight: 4.47%
  • CSPC Pharmaceutical Group Limited
    Holding Weight: 4.05%
  • WuXi AppTec Co., Ltd.
    Holding Weight: 3.78%
  • Sino Biopharmaceutical Limited
    Holding Weight: 3.32%
  • Zhangzhou Pientzehuang Pharmaceutical., Ltd
    Holding Weight: 3.25%

KURE Sector Exposure

KURE Industry Exposure


This page (NYSEARCA:KURE) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners